BioCryst Pharmaceuticals
BCRX
#5073
Rank
ยฃ1.19 B
Marketcap
ยฃ5.69
Share price
-3.07%
Change (1 day)
-4.62%
Change (1 year)

BioCryst Pharmaceuticals (BCRX) - Cash on Hand

Cash on Hand as of September 2025 : ยฃ0.15 Billion

According to BioCryst Pharmaceuticals 's latest financial reports the company has ยฃ0.15 Billion in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

BioCryst Pharmaceuticals - Cash on Hand chart (from 1996 to 2025)

Cash on Hand by year

Year Cash on Hand Change
2024-12-31ยฃ0.25 B-16.26%
2023-12-31ยฃ0.30 B-12.94%
2022-12-31ยฃ0.35 B-6.73%
2021-12-31ยฃ0.37 B70.65%
2020-12-31ยฃ0.22 B112.12%
2019-12-31ยฃ0.10 B26.23%
2018-12-31ยฃ82.29 M-2.77%
2017-12-31ยฃ84.64 M91.11%
2016-12-31ยฃ44.29 M27.29%
2015-12-31ยฃ34.79 M-25.56%
2014-12-31ยฃ46.74 M102.6%
2013-12-31ยฃ23.07 M4.75%
2012-12-31ยฃ22.02 M-17.94%
2011-12-31ยฃ26.84 M-23.19%
2010-12-31ยฃ34.94 M-18%
2009-12-31ยฃ42.61 M1.52%
2008-12-31ยฃ41.98 M64.51%
2007-12-31ยฃ25.51 M33.45%
2006-12-31ยฃ19.12 M-34.39%
2005-12-31ยฃ29.14 M141.46%
2004-12-31ยฃ12.07 M7.81%
2003-12-31ยฃ11.19 M-26.57%
2002-12-31ยฃ15.24 M-30.89%
2001-12-31ยฃ22.06 M33.66%
2000-12-31ยฃ16.5 M15.46%
1999-12-31ยฃ14.29 M93.27%
1998-12-31ยฃ7.39 M219.77%
1997-12-31ยฃ2.31 M10.03%
1996-12-31ยฃ2.1 M

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
Repligen
RGEN
ยฃ0.56 B 251.73%๐Ÿ‡บ๐Ÿ‡ธ USA
Sarepta Therapeutics
SRPT
ยฃ0.63 B 299.77%๐Ÿ‡บ๐Ÿ‡ธ USA
NanoViricides
NNVC
ยฃ1.16 M-99.27%๐Ÿ‡บ๐Ÿ‡ธ USA
Novavax
NVAX
ยฃ0.57 B 258.38%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
ยฃ5.51 B 3,352.29%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
ยฃ0.43 B 173.98%๐Ÿ‡บ๐Ÿ‡ธ USA
GlaxoSmithKline
GSK
ยฃ3.33 B 1,987.81%๐Ÿ‡ฌ๐Ÿ‡ง UK
Emergent BioSolutions
EBS
ยฃ0.18 B 15.33%๐Ÿ‡บ๐Ÿ‡ธ USA
Cel-Sci
CVM
ยฃ1.34 M-99.16%๐Ÿ‡บ๐Ÿ‡ธ USA